6533b7dcfe1ef96bd1271e49
RESEARCH PRODUCT
Enteral tube feeding and mortality in hospitalized older patients: A multicenter longitudinal study
Romina CustureriMario DurandoGiacomo SiriAlfonso J. Cruz-jentoftAngelique EgbertsDaniele SancarloPavla MadlovaStefania MaggiArduino A. MangoniHelena MichalkovaAlberto PilottoBeatriz Montero-errasquínE TopinkovaAnna Maria MeyerJulia DaragjatiFrancesco U.s. Mattace-rasoRalf-joachim SchulzNicola VeroneseMaria Cristina PolidoriMarie-laure BureauCarmen Miret-corchadoAlberto CellaLuigi FerrucciThomas BrunetGrazia D'onofrioAntonio GrecoMarc PaccalinMatteo PuntoniMatteo SimonatoDirk HoffmannClarissa MusacchioLisanne TapEvelyne LiuuKimberley Ruxtonsubject
Male0301 basic medicinemedicine.medical_specialtyLongitudinal studyPrognosis.030209 endocrinology & metabolismCritical Care and Intensive Care MedicineHospital03 medical and health sciences0302 clinical medicineMultidimensional prognostic indexOdds RatiomedicineRisk of mortalityHumansLongitudinal StudiesMortalityAgedEnteral Tube FeedingAged 80 and overInpatients030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryMedical recordAustraliaOdds ratioConfidence intervalEuropeParenteral nutritionEmergency medicinePropensity score matchingFemaleEnteral nutritionbusinessdescription
Background & aims: The literature regarding enteral nutrition and mortality in older frail people is limited and still conflicting. Moreover, the potential role of comprehensive geriatric assessment is poorly explored. We therefore aimed to investigate whether the Multidimensional Prognostic Index (MPI), an established tool that assesses measures of frailty and predicts mortality, may help physicians in identifying patients in whom ETF (enteral tube feeding) is effective in terms of reduced mortality. Methods: Observational, longitudinal, multicenter study with one year of follow-up. Data regarding ETF were recorded through medical records. A standardized comprehensive geriatric assessment was used to calculate the MPI. Participants were divided in low (MPI-1), moderate (MPI-2) or severe (MPI-3) risk of mortality. Data regarding mortality were recorded through administrative information. Results: 1064 patients were included, with 79 (13 in MPI 1–2 and 66 in MPI-3 class) receiving ETF. In multivariable analysis, patients receiving ETF experienced a higher risk of death (odds ratio, OR = 2.00; 95% confidence intervals, CI: 1.19–3.38). However, after stratifying for their MPI at admission, mortality was higher in MPI-3 class patients (OR = 2.03; 95%CI: 1.09–3.76), but not in MPI 1–2 class patients (OR = 1.51; 95%CI: 0.44–5.25). The use of propensity score confirmed these findings. Conclusions: ETF is associated with a higher risk of death. However, this is limited to more frail patients, suggesting the importance of the MPI in the prognostic evaluation of ETF. © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism
year | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 | Clinical Nutrition |